Skip to main content
David Badesch, MD, Pulmonology, Aurora, CO, University of Colorado Hospital

DavidBadeschMD

Pulmonology Aurora, CO

Critical Care Medicine, Pulmonary Vascular Medicine

Professor of Medicine, University Colorado

Dr. Badesch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Badesch's full profile

Already have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1989
  • University of Colorado
    University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1987
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1986
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1983

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1987 - 2025
  • TN State Medical License
    TN State Medical License 1985 - 1995
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Advances in Pulmonary & Critical Care Medicine 
    Inova Health System, Falls Church, Virginia - 3/16/2013

Press Mentions

  • Time from PAH Diagnosis Impacts Prognosis, Response to Selexipag
    Time from PAH Diagnosis Impacts Prognosis, Response to SelexipagAugust 5th, 2021
  • Clinical Challenges: Genetic Insights into Pulmonary Arterial Hypertension
    Clinical Challenges: Genetic Insights into Pulmonary Arterial HypertensionNovember 2nd, 2020
  • Acceleron Announces Initiation of PULSAR Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension
    Acceleron Announces Initiation of PULSAR Phase 2 Trial of Sotatercept in Pulmonary Arterial HypertensionMay 22nd, 2018
  • Join now to see all

Hospital Affiliations